Working paper
Methods for determining the extent of added benefit - empirical data from dossier assessments
Report documents
-
Extract of the working paper
Methods for determining the extent of added benefit - empirical data from dossier assessments
-
Working paper
Methods for determining the extent of added benefit - empirical data from dossier assessments
Press releases
Determining the extent of added benefit of new drugs in dossier assessments: Have IQWiG's methods worked in practice?
Are the expected effect sizes for the extent of added benefit actually reached in most cases? This was analysed in a recent working paper based on more than 1000 results from over ten years of assessments.
Project details
- Project no.
- GA23-01
- Report type
- Working paper
- Status
- Commission completed
- Department/Division
- Drug Assessment
- DOI
https://doi.org/10.60584/GA23-01_V1.1_en